Lubiprostone Capsule, Gelatin Coated
Product Images NDC 82804-304

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 82804-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-304-60 (Image 01)

82804-304-60 (Image 01)
Label for Lubiprostone 24 mcg capsules, gelatin-coated soft gel oral capsules, with a quantity of 60. Presented by Proficient Rx LP and manufactured for Teva Pharmaceuticals, Parsippany, NJ. The label includes storage instructions, medication handling warnings, and various lot and expiration placeholders along with barcodes and a QR code.*
FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure diagram of Lubiprostone, showing its molecular bonds and functional groups including carboxylic acid, ketone, hydroxyl, and fluorine atoms in a multicyclic framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.